Document ID: chunk:federal_register_of_legislation:F2016L01489:body:0:p2
Version: federal_register_of_legislation:F2016L01489
Segment Type: other
Provision Reference: 
Character Range: 2818–4396

A warrant issuer that complies with section 1017B of the Act as if subsection 1017B(2) were omitted is exempt from:
(a) section 1013I of the Act in relation to a Product Disclosure Statement or Short-Form PDS that relates to an exchange-traded managed investment warrant of the warrant issuer;
(b) section 1015B of the Act in relation to a Product Disclosure Statement that relates to an exchange-traded managed investment warrant of the warrant issuer; and
(c) section 1017D of the Act in relation to an exchange-traded managed investment warrant of the warrant issuer.

            Note 1: The consequences of relying on the exemption from section 1015B of the Act include paragraph 1013G(a), section 1013J and subsection 1016B(1) of the Act not applying in relation to the relevant Product Disclosure Statement, and section 1015D of the Act applying in relation to that Statement.

            Note 2: Section 1015B of the Act does not apply to a Short-Form PDS.
(2) A warrant issuer is exempt from the disclosing entity provisions where the warrant issuer is a disclosing entity only because one or more classes of exchange-traded managed investment warrants of the warrant issuer are ED securities.

       Part 3—Declaration

6 Exchange-traded warrants
(1) Part 7.9 of the Act applies in relation to an exchange-traded warrant as if item 3 in the table in subsection 761E(3) of the Act were omitted.
(2) Subsection (1) applies where the exchange-traded warrant is acquired on the financial market in relation to which it has been admitted to trading status or quotation.